![Jane Chung](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jane Chung
Chief Executive Officer at
SUTRO BIOPHARMA, INC.
Net worth: 435 868 $ as of 2026-08-30
Profile
Jane Chung is President, Chief Executive Officer, COO & Director at Sutro Biopharma, Inc. since 2025.
Former roles include Independent Director at Viracta Therapeutics, Inc. from 2022 to 2024, President & General Manager at AstraZeneca Canada, Inc. from 2015 to 2021, Director-Sales Productivity & Effectiveness at Onyx Pharmaceuticals, Inc. from 2013 to 2015, and Senior Manager-Marketing at Genentech, Inc. from 2003 to 2013.
Education includes undergraduate studies at The Trustees of Columbia University in The City of New York and St. John's University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-03-30 | 21,535 ( 0.13% ) | 435 868 $ | 2026-08-30 |
Jane Chung active positions
| Companies | Position | Start |
|---|---|---|
| SUTRO BIOPHARMA, INC. | Chief Executive Officer | 2025-03-12 |
Former positions of Jane Chung
| Companies | Position | End |
|---|---|---|
| VIRACTA THERAPEUTICS, INC. | Director/Board Member | 2024-10-30 |
AstraZeneca Canada, Inc.
 AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drug preparations | President | 2021-07-31 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Corporate Officer/Principal | 2014-12-31 |
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Sales & Marketing | 2012-12-31 |
Training of Jane Chung
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
92
1st degree connections
7
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 7 |
|---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
Sutro Biopharma, Inc.
 Sutro Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Develops new products in protein vaccines and therapeutics | Health Technology |
The Trustees of Columbia University in The City of New York
 The Trustees of Columbia University in The City of New York Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
St. John's University
 St. John's University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AstraZeneca Canada, Inc.
AstraZeneca Canada, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical drug preparations | Health Technology |
Viracta Therapeutics, Inc.
 Viracta Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for virus-associated cancers | Health Technology |
- Stock Market
- Insiders
- Jane Chung
